Osaver Hct (Olmesartan Medoxomil, Hydrochlorothiazide)

Osaver Hct, a combination antihypertensive, acts on the renin‑angiotensin system and promotes diuresis to manage high blood pressure.

• Hypertension: reduces systolic and diastolic blood pressure in adults with essential hypertension.
• High‑risk cardiovascular patients: helps achieve target blood pressure when monotherapy is insufficient.
• Patients requiring diuretic therapy: adds fluid‑excreting effect to improve blood pressure control.

• Olmesartan medoxomil blocks the angiotensin II type 1 (AT1) receptor, preventing vasoconstriction and aldosterone release, while hydrochlorothiazide inhibits sodium‑chloride reabsorption in the distal convoluted tubule, increasing urinary excretion of sodium and water. The combined actions lower peripheral vascular resistance and plasma volume, resulting in reduced arterial pressure.

Common Side Effects

• Dizziness: feeling light‑headed, especially after standing.
• Headache: mild to moderate pain in the head region.
• Fatigue: general tiredness or lack of energy.
• Increased urination: more frequent need to void.
• Electrolyte imbalance: low potassium or sodium levels.
• Dry mouth: reduced salivation.

Serious or Rare Side Effects

• Severe hypotension: dangerously low blood pressure.
• Kidney impairment: reduced renal function or acute kidney injury.
• Hyperkalemia: elevated potassium levels.
• Angioedema: swelling of face, lips, tongue, or throat.
• Pancreatitis: inflammation of the pancreas.
• Anaphylactic reaction: severe allergic response requiring emergency care.

Before starting Osaver Hct, consider the following precautions:

• Monitor blood pressure: ensure adequate control and avoid excessive lowering.
• Assess renal function: check creatinine and eGFR regularly.
• Check electrolytes: especially potassium and sodium levels.
• Avoid use in pregnancy: drug may harm the fetus.
• Use caution in liver disease: dose adjustment may be needed.
• Store at room temperature: keep in the original container, protect from moisture and light.

Osaver Hct can interact with several medicines. Review the following groups:

Major Interactions (Avoid)

• Aliskiren (in diabetic patients): combined use may increase risk of renal dysfunction.
• Potassium‑sparing diuretics (e.g., spironolactone): may cause hyperkalemia.
• NSAIDs (e.g., ibuprofen): can blunt antihypertensive effect and affect kidney function.
• Lithium: increased lithium levels and toxicity risk.

Moderate Interactions (Monitor Closely)

• ACE inhibitors: additive blood pressure lowering, monitor for hypotension.
• Beta‑blockers: may enhance antihypertensive effect, watch for bradycardia.
• Antidiabetic agents: diuretic may affect glucose control, adjust monitoring as needed.